What's new in local drug delivery,
from Japan to the world.
DoseAt Site is a bilingual (English and Japanese) news site on local drug delivery: getting the right amount of a drug to exactly where it is needed, such as the subretinal space, the inner ear or a tumor. We cover approvals, clinical studies, technologies and conferences.
Get notified at launchWhat we cover
Delivery routes, and the devices and regulations behind them.
Ophthalmology
Subretinal, intravitreal and suprachoroidal delivery
Otology and inner ear
Intratympanic and intracochlear delivery, gene therapy
Oncology
Intratumoral and intra-arterial delivery, neoadjuvant therapy
Central nervous system
Intrathecal and intracerebroventricular delivery
Transdermal and mucosal
Microneedles, intranasal delivery
Implants and depots
Intraocular implants, long-acting formulations
Delivery devices
Precision pumps, microinjectors
Regulation
PMDA, FDA, EMA and CDSCO updates
Why DoseAt Site
Primary sources
We summarize regulatory announcements, papers and conference news, always with links to the original source.
Japan, in English
We bring Japanese approvals and conference trends to readers outside Japan.
Editor-reviewed
Articles are drafted with AI and published only after our editors check the content and sources.
Pre-register
Sign up and we will send you:
- A notice when the site launches (planned for November 2026)
- An invitation to our newsletter when it starts (only if you opt in)
Please read how we handle your personal information before signing up.